Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Things I'd like to hear discussed at 2nd Q CC next Thurs, Aug 9th at 4:30.

1) Why the delay in getting international sites for SPPIs pozi ex20in trial; it's been since early May that JTs team went over there to recruit sites. There might not be a delay, it might just take that long to get a site going but I think an explanation is in order.

2) Why is it taking so much time to start the pan HER2ex20in trial. Will the pan HER2ex20in trial be pivotal i.e. just having the trial at MDA won't cut it, it will need to be a multi-site trial. And if multi-site, will it be international? And the last time you discussed this trial, you were talking pan HER2 (in 28 tumor types). Why not in EGFR? Or are you really referring to both HER2 and EGFR.

3) And other things pozi such as when will we get top-line on the breast cancer study? I'm not thinking about SPPIs pan HER2ex20in trial since we'll know how that will work out when we get an update from MDA in Sept on their trial.

4) Any other pozi (combo) trials planned?

5) Rolontis- are your 4th Q submission timelines still current?

6) Any color on being acquired? How serious. How far apart? More than 1 company interested?

7) Any licensing deals in the works?